Washington, D.C., October 5, 2026 – The Multidisciplinary Association for Psychedelic Studies (MAPS) announced a new strategic partnership with the International Alliance of Psychedelic Therapy Practitioners …
Washington, D.C., September 17, 2026 — The FDA’s September 14 hearing marked one of the most consequential regulatory moments for psychedelic-assisted therapy to date. The Multidisciplinary Association …
Washington, D.C., August 25, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS)has welcomed the announcement that the University of Miami has gifted the federal government its 1994 …
August 10, 2026 — The non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) today responded to an August 9 report by Psychedelic Alpha indicating that Resilient Pharmaceuticals (formerly …
Washington, D.C., July 7, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) released an Ibogaine Investigator’s Brochure (IB), a comprehensive scientific and regulatory resource …
June, 25, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) announced the opening of speaker submission for Psychedelic Science 2027 (PS27), its flagship conference for psychedelic …
June 18, 2026 — In United States v. Hemani, the U.S. Supreme Court ruled today that the federal government’s prosecution of Ali Hemani under a provision of the Gun Control Act violated the Second …
Washington, D.C., June 2, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) today announced its Psychedelics for System-Impacted People (PSIP) project, a research, education, and …
Denver, Colorado; May 13, 2026 —The Multidisciplinary Association for Psychedelic Studies (MAPS) announced that early bird registrations are now open for Psychedelic Science 2027 (PS27), taking place …
SAN JOSE, CA; May 7, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) today announced the addition of Liana Sananda Gillooly and Andrew “Mo” Septimus to its Board of Directors. …
DENVER, May 5, 2026 — The Multidisciplinary Association for Psychedelic Studies (MAPS) announced a partnership with the Colorado Department of Revenue’s Natural Medicine Division to provide MAPS’ …
Washington DC — Reps. Jack Bergman (R-MI) and Lou Correa (D-CA), co-chairs of the Congressional Psychedelics Advancing Therapies Caucus, led a bipartisan group of 30 members of Congress in a letter to …
